檢索結果 - Lukas C. Amler

Refine Results
  1. 1
    Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA.

    Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. 由 Lukas C. Amler, M. Schwab

    出版 1989
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Genomic instability in Ip and human malignancies

    Genomic instability in Ip and human malignancies 由 Manfred Schwab, Christian Praml, Lukas C. Amler

    出版 1996
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer

    Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patient... 由 Edith A. Perez, Sara A. Hurvitz, Lukas C. Amler, Kirsten Mundt, Vivian Ng, Ellie Guardino, Luca Gianni

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation

    Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation 由 Shyhmin Huang, Chunrong Li, Eric A. Armstrong, Chimera R. Peet, Jarob Saker, Lukas C. Amler, Mark X. Sliwkowski, Paul M. Harari

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays

    Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays 由 Zachary Boyd, Qun Wu, Carol O’Brien, Jill M. Spoerke, Heidi Savage, Paul J. Fielder, Lukas C. Amler, Yibing Yan, Mark R. Lackner

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis

    A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis 由 Nicholas Dompe, Celina Sanchez Rivers, Li Li, Shaun Cordes, Martin Schwickart, Elizabeth A. Punnoose, Lukas C. Amler, Somasekar Seshagiri, Jerry Tang, Zora Modrušan, David P. Davis

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast Cancer

    Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast Cancer 由 Carol O’Brien, Guy Cavet, Ajay Pandita, Xiaolan Hu, Lauren E. Haydu, Sankar Mohan, Karen Toy, Celina Sanchez Rivers, Zora Modrušan, Lukas C. Amler, Mark R. Lackner

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Molecular Biomarker Analyses Using Circulating Tumor Cells

    Molecular Biomarker Analyses Using Circulating Tumor Cells 由 Elizabeth A. Punnoose, Siminder Atwal, Jill M. Spoerke, Heidi Savage, Ajay Pandita, Ru‐Fang Yeh, Andrea Pirzkall, Bernard M. Fine, Lukas C. Amler, Daniel S. Chen, Mark R. Lackner

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib

    Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib 由 Linda Mileshkin, Rodney J. Hicks, Brett Hughes, Paul Mitchell, Veena Charu, Barbara J. Gitlitz, David Macfarlane, Benjamin Solomon, Lukas C. Amler, Wei Yu, Andrea Pirzkall, Bernard M. Fine

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

    Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Er... 由 Elizabeth A. Punnoose, Siminder Atwal, Weiqun Liu, Rajiv Raja, Bernard M. Fine, Brett Hughes, Rodney J. Hicks, Garret M. Hampton, Lukas C. Amler, Andrea Pirzkall, Mark R. Lackner

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer

    Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer 由 Jiping Zha, Carol O’Brien, Heidi Savage, Ling‐Yuh Huw, Fiona Zhong, Leanne Berry, Gail D. Lewis Phillips, Elizabeth Luis, Guy Cavet, Xiaolan Hu, Lukas C. Amler, Mark R. Lackner

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing

    High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing 由 Richard Bourgon, Shan Lu, Yibing Yan, Mark R. Lackner, Weiru Wang, Victor Weigman, David Wang, Yinghui Guan, Lisa Ryner, Hartmut Koeppen, Rajesh Patel, Garret M. Hampton, Lukas C. Amler, Yulei Wang

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer

    Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer 由 Lisa Ryner, Yinghui Guan, Ron Firestein, Yuanyuan Xiao, Younjeong Choi, Christina Rabe, Shan Lu, Eloisa Fuentes, Ling‐Yuh Huw, Mark R. Lackner, Ling Fu, Lukas C. Amler, Carlos Bais, Yulei Wang

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine

    A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab,... 由 Ian E. Krop, Patricia LoRusso, Kathy D. Miller, Shanu Modi, Denise A. Yardley, Gladys Rodriguez, Ellie Guardino, Michael W. Lu, Maoxia Zheng, Sandhya Girish, Lukas C. Amler, Eric P. Winer, Hope S. Rugo

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models

    Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models 由 Carol O’Brien, Jeffrey J. Wallin, Deepak Sampath, Debraj GuhaThakurta, Heidi Savage, Elizabeth A. Punnoose, Jane Guan, Leanne Berry, Wei Wei Prior, Lukas C. Amler, Marcia Belvin, Lori S. Friedman, Mark R. Lackner

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Epithelial versus Mesenchymal Phenotype Determines <i>In vitro</i> Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

    Epithelial versus Mesenchymal Phenotype Determines <i>In vitro</i> Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients 由 Robert L. Yauch, Thomas Januario, David A. Eberhard, Guy Cavet, Wenjing Zhu, Ling Fu, Thinh Q. Pham, Robert Soriano, Jeremy Stinson, Somasekar Seshagiri, Zora Modrušan, Chin‐Yu Lin, Vincent O’Neill, Lukas C. Amler

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia

    A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia 由 Marie-Claire Wagle, Anna M. Eiring, Matthew Wongchenko, Shaoyong Lu, Yinghui Guan, Yulei Wang, Mark R. Lackner, Lukas C. Amler, Garret M. Hampton, Michael W. Deininger, Thomas O’Hare, Ying-Li WuHua Yan

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

    Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for t... 由 Giampaolo Bianchini, Astrid Kiermaier, Giulia Bianchi, Young‐Hyuck Im, Tadeusz Pieńkowski, Mei-Ching Liu, Ling‐Ming Tseng, Mitch Dowsett, Lila Zabaglo, S Kirk, Tania Szado, Jennifer Eng‐Wong, Lukas C. Amler, Pinuccia Valagussa, Luca Gianni

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer

    Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer 由 Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha, Wenjing Zhu, Kaumudi Bhawe, Nerissa Mendoza, Thomas Holcomb, Kanan Pujara, Jeremy Stinson, Ling Fu, Christophe Severin, Linda Rangell, Ralph Schwall, Lukas C. Amler, Dineli Wickramasinghe, Robert L. Yauch

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer 由 Sharmila Makhija, Lukas C. Amler, D. Glenn, Frederick R. Ueland, Michael A. Gold, Don S. Dizon, Virginia Paton, Chin‐Yu Lin, Thomas Januario, Kimmie Ng, Andreas C. Strauß, Stephen M. Kelsey, Mark X. Sliwkowski, Ursula A. Matulonis

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: